Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 6/20 | 0.63 |
| ▸ | PPARG | P37231 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | PTGIR | P43119 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30690430 | 1.00 | PPARA (0.63) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL20779106 | 0.95 | PPARA (0.57) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL4452302 | 0.93 | PPARA (0.55) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL32675259 | 0.93 | PPARA (0.55) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL12809420 | 0.93 | PPARA (0.55) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL27749391 | 0.93 | PPARA (0.54) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL8469317 | 0.93 | ALDH1A1 (0.60) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL4648034 | 0.93 | ALDH1A1 (0.60) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL8507559 | 0.88 | TP53 (0.64) | PPARAPPARGALDH1A1TP53CYP3A4 | |
| SCHEMBL38657149 | 0.88 | TP53 (0.64) | PPARAPPARGALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | THE UNIVERSITY OF AKRON | 2020-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | GSTO1, FDFT1, DGAT2 | PPARA 811/4885PPARG 981/4885ALDH1A1 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.